Indian Government should pay immediate action to a study which says that Millions of unapproved antibiotics are being sold in India, by researchers at Queen Mary University of London and Newcastle University.The research, published today in the British Journal of Clinical Pharmacology, found that multinational companies continued to manufacture many unapproved formulations, despite pledging to tackle rising antimicrobial resistance for their benefits and earn money. These findings highlight serious hurdles for controlling antimicrobial resistance in India, which has among the highest antibiotic consumption rates and sales in the world and has had parliamentary investigations into failures of the country's drug regulatory system.The researchers examined figures for fixed dose combination (FDC) antibiotics (formulations composed of two or more drugs in a single pill) and single drug…